Inventor

KOENIG SCOTT

US57 patents

⚠️ This page may combine multiple inventors who share the name “KOENIG SCOTT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KOENIG SCOTT

MACROGENICS INC

FcγRIIB specific antibodies and methods of use thereof

FcγRIIB specific antibodies and methods of use thereof

PD-1-binding molecules and methods of use thereof

Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereof

PD-1-binding molecules and methods of use thereof

Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγRactivating and FcγRinhibiting

Methods for the treatment of disease using immunoglobulins having Fc Regions with altered affinities for FcγRactivating and FcγRinhibiting

Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof

Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof

LAG-3-binding molecules and methods of use thereof

Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereof

LAG-3-binding molecules and methods of use thereof

Bi-specific monovalent diabodies that are capable of binding CD19 and CD3, and uses thereof

Bispecific molecules having immunoreactivity with PD-1 and CTLA-4, and methods of use thereof

Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof

Combination therapy for the treatment of cancer

Combination therapy for the treatment of cancer

Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4

MEDIMMUNE INC

Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment

Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment

Anti-RSV antibodies

Immunogenic pneumococcal protein and vaccine compositions thereof

Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment

Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment

Methods of enhancing activity of vaccines and vaccine compositions

Derivatives of choline binding proteins for vaccines

Pneumococcal protein homologs and fragments for vaccines

Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response

Derivatives of choline binding proteins for vaccines

Derivatives of choline binding proteins for vaccines

KOENIG SCOTT

FcγRIIB specific antibodies and methods of use thereof

FcγRIIB specific antibodies and methods of use thereof

FcγRIIB specific antibodies and methods of use thereof

FcγRIIB-specific antibodies and methods of use thereof

Mobile device case with retractor reel assembly for user-provided headphones

Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity

FcγRIIB specific antibodies and methods of use thereof

FcγRIIB specific antibodies and methods of use thereof

Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity

Mobile device case with retractor reel assembly for user-provided headphones

MEDIMMUNE LLC

Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment

Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment

Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment

ST JUDE CHILDRENS RES HOSPITAL

Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof

Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof

STAVENHAGEN JEFFREY

Engineering Fc antibody regions to confer effector function

STAVENHAGEN JEFFREY B

Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγRactivating and FcγRinhibiting

UNIV BRITISH COLUMBIA

Caulobacter LPS immunoadjuvants

(unassigned)

Skelly game

UNIV DUKE

Bispecific molecules comprising an HIV-1 envelope targeting arm